menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    02 January 2018 Final meeting in Lyon

    M54 meeting will be organised by CLB partner on 5 and 6 February 2018.
    More >>


    10 July 2017 M48 meeting in Marseille

    Our consortium will meet in Marseille on 6 and 7 September 2017. Innate Pharma kindly organizes this M48 meeting.More >>


    Displaying results 1 to 2 out of 9
    Brochure